147 related articles for article (PubMed ID: 11851737)
1. Single event multilevel botulinum toxin type A treatment and surgery: similarities and differences.
Molenaers G; Desloovere K; De Cat J; Jonkers I; De Borre L; Pauwels P; Nijs J; Fabry G; De Cock P
Eur J Neurol; 2001 Nov; 8 Suppl 5():88-97. PubMed ID: 11851737
[TBL] [Abstract][Full Text] [Related]
2. A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures.
Desloovere K; Molenaers G; Jonkers I; De Cat J; De Borre L; Nijs J; Eyssen M; Pauwels P; De Cock P
Eur J Neurol; 2001 Nov; 8 Suppl 5():75-87. PubMed ID: 11851736
[TBL] [Abstract][Full Text] [Related]
3. The effects of quantitative gait assessment and botulinum toxin a on musculoskeletal surgery in children with cerebral palsy.
Molenaers G; Desloovere K; Fabry G; De Cock P
J Bone Joint Surg Am; 2006 Jan; 88(1):161-70. PubMed ID: 16391261
[TBL] [Abstract][Full Text] [Related]
4. Single-event multilevel surgery, but not botulinum toxin injections normalize joint loading in cerebral palsy patients.
Van Rossom S; Kainz H; Wesseling M; Papageorgiou E; De Groote F; Van Campenhout A; Molenaers G; Desloovere K; Jonkers I
Clin Biomech (Bristol, Avon); 2020 Jun; 76():105025. PubMed ID: 32402900
[TBL] [Abstract][Full Text] [Related]
5. [Botulinum toxin for postoperative care after limb surgery in cerebral palsy children].
Dohin B; Garin C; Vanhems P; Kohler R
Rev Chir Orthop Reparatrice Appar Mot; 2007 Nov; 93(7):674-81. PubMed ID: 18065878
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin injections minimally affect modelled muscle forces during gait in children with cerebral palsy.
Wesseling M; Kainz H; Hoekstra T; Van Rossom S; Desloovere K; De Groote F; Jonkers I
Gait Posture; 2020 Oct; 82():54-60. PubMed ID: 32892101
[TBL] [Abstract][Full Text] [Related]
7. Motor function following multilevel botulinum toxin type A treatment in children with cerebral palsy.
Desloovere K; Molenaers G; De Cat J; Pauwels P; Van Campenhout A; Ortibus E; Fabry G; De Cock P
Dev Med Child Neurol; 2007 Jan; 49(1):56-61. PubMed ID: 17209978
[TBL] [Abstract][Full Text] [Related]
8. Literature Review and Comparison of Two Statistical Methods to Evaluate the Effect of Botulinum Toxin Treatment on Gait in Children with Cerebral Palsy.
Nieuwenhuys A; Papageorgiou E; Pataky T; De Laet T; Molenaers G; Desloovere K
PLoS One; 2016; 11(3):e0152697. PubMed ID: 27030973
[TBL] [Abstract][Full Text] [Related]
9. Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study.
Franzén M; Hägglund G; Alriksson-Schmidt A
BMC Musculoskelet Disord; 2017 Dec; 18(1):520. PubMed ID: 29228927
[TBL] [Abstract][Full Text] [Related]
10. Treatment of functional limitations at the knee in ambulatory children with cerebral palsy.
Chambers HG
Eur J Neurol; 2001 Nov; 8 Suppl 5():59-74. PubMed ID: 11851735
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin a treatment in children with cerebral palsy: its effects on walking and energy expenditure.
Balaban B; Tok F; Tan AK; Matthews DJ
Am J Phys Med Rehabil; 2012 Jan; 91(1):53-64. PubMed ID: 22157436
[TBL] [Abstract][Full Text] [Related]
12. Preoperative botulinum toxin test injections before muscle lengthening in cerebral palsy.
Rutz E; Hofmann E; Brunner R
J Orthop Sci; 2010 Sep; 15(5):647-53. PubMed ID: 20953926
[TBL] [Abstract][Full Text] [Related]
13. Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure.
Linder M; Schindler G; Michaelis U; Stein S; Kirschner J; Mall V; Berweck S; Korinthenberg R; Heinen F
Eur J Neurol; 2001 Nov; 8 Suppl 5():120-6. PubMed ID: 11851740
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
Read FA; Boyd RN; Barber LA
Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
[TBL] [Abstract][Full Text] [Related]
15. Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: clinical implications.
Autti-Rämö I; Larsen A; Taimo A; von Wendt L
Eur J Neurol; 2001 Nov; 8 Suppl 5():136-44. PubMed ID: 11851742
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of botulinum toxin A lower limb injections in addition to physiotherapy approaches in children with cerebral palsy: A systematic review.
Yana M; Tutuola F; Westwater-Wood S; Kavlak E
NeuroRehabilitation; 2019; 44(2):175-189. PubMed ID: 30856126
[TBL] [Abstract][Full Text] [Related]
17. Managing spasticity in pediatric cerebral palsy using a very low dose of botulinum toxin type A: preliminary report.
Suputtitada A
Am J Phys Med Rehabil; 2000; 79(4):320-6. PubMed ID: 10892617
[TBL] [Abstract][Full Text] [Related]
18. Muscle synergies demonstrate only minimal changes after treatment in cerebral palsy.
Shuman BR; Goudriaan M; Desloovere K; Schwartz MH; Steele KM
J Neuroeng Rehabil; 2019 Mar; 16(1):46. PubMed ID: 30925882
[TBL] [Abstract][Full Text] [Related]
19. Changes of kinematics parameters of pelvis during walking under the influence of means facilitates treatment of cerebral palsied children.
Czupryna K; Nowotny J
Ortop Traumatol Rehabil; 2012; 14(5):453-65. PubMed ID: 23208937
[TBL] [Abstract][Full Text] [Related]
20. [Botulinum toxin A in the treatment of infantile cerebral palsy. Taking into account multilevel, integrated treatment].
Molenaers G; Desloovere K; De Cat J
Orthopade; 2004 Oct; 33(10):1119-28. PubMed ID: 15278274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
